Lombard Odier Asset Management (Switzerland)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-242,248
| Closed | -$2.15M | – | 405 |
|
|
2022
Q4 | $2.15M | Hold |
242,248
| – | – | 0.17% | 115 |
|
|
2022
Q3 | $2.97M | Sell |
242,248
-17,584
| -7% | -$215K | 0.25% | 94 |
|
|
2022
Q2 | $3.07M | Sell |
259,832
-121,131
| -32% | -$1.43M | 0.26% | 93 |
|
|
2022
Q1 | $7.25M | Buy |
380,963
+67,641
| +22% | +$1.29M | 0.57% | 52 |
|
|
2021
Q4 | $8.32M | Buy |
313,322
+104,818
| +50% | +$2.78M | 0.53% | 56 |
|
|
2021
Q3 | $8.57M | Sell |
208,504
-94,629
| -31% | -$3.89M | 0.53% | 67 |
|
|
2021
Q2 | $17.2M | Buy |
303,133
+113,939
| +60% | +$6.45M | 0.87% | 49 |
|
|
2021
Q1 | $7.95M | Buy |
+189,194
| New | +$7.95M | 0.53% | 61 |
|